Home > Product > Galantamine SR
| CATEGORY |
PRODUCT PROFILE |
| PRODUCT NAME |
Tamirin SR (Galantamine Sustained Release) Tablet
(Original : Reminyl PR Capsule from Janssen)
|
| COMPANY |
Hyundai Pharm Co. Ltd. |
DEVELOPMENT
STATUS |
Launched in Korea in September 2009
(All three strengths : 8mg, 16mg & 24mg)
|
| THERAPEUTIC AREA |
Dementia from Alzheimer’s Disease |
| ACTION |
Acetylcholinesterase inhibitor |
| STRENGTH |
- Diffusion Matrix type SR formulation with identical multi-strength release profile
- Differentiation from capsule formulation (Unique formulation patent)
- Tablet formulation patent in Korea & PCT available
- 1st to launch all strengths of Galantamine SR tablet in Asia
- Simplified manufacturing process = Low manufacturing cost
- Independence on GI movement and pH
|
| TECHNOLOGY |
SR Platform / Diffusion Matrix |
